Target intelligence / Profile preview

Cutaneous sensory nerve excitability

Molecular classification
Ion channel, Receptor, Other
01

Overview

Cutaneous sensory nerve excitability refers to the physiological capacity of peripheral sensory neurons to generate and propagate action potentials in response to external stimuli (Bostock et al., 1998). This process is fundamentally regulated by the coordinated activity of various ion channels, including voltage-gated sodium (Nav), potassium (K+), and calcium (Ca2+) channels, as well as transient receptor potential (TRP) channels (Waxman & Zamponi, 2014). In healthy states, these channels maintain a stable resting membrane potential and ensure appropriate responses to thermal, mechanical, or chemical stimuli. However, in pathological conditions such as neuropathic pain or peripheral neuropathy, these nerves often become hyperexcitable, leading to spontaneous firing and symptoms like allodynia or hyperalgesia (Baron et al., 2010). Pharmacological agents targeting this excitability typically act by blocking sodium channels or modulating potassium and calcium conductance to restore normal firing thresholds. While cutaneous sensory nerve excitability is a physiological phenomenon rather than a single molecular entity, it represents a critical functional endpoint in the development of analgesics and treatments for sensory disorders (Namer et al., 2019).

Other names
Peripheral nerve excitabilitySensory axonal excitabilityCutaneous nerve membrane potentialNerve excitability
02

Mechanism of action

Modulation of voltage-gated sodium, potassium, and calcium channels to stabilize membrane potential and increase the threshold for action potential generation.

03

Biological functions

Signal transductionSensory perceptionNociceptionAction potential propagation
04

Disease associations

Neuropathic painPeripheral neuropathyPruritusErythromelalgiaSmall fiber neuropathy
05

Safety considerations

Sensory lossParesthesiaDizzinessAtaxiaCardiac conduction abnormalities (for systemic sodium channel blockers)
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Threshold trackingMicroneurographyQuantitative sensory testing (QST)Skin biopsy (nerve fiber density)

Beyond the preview

Go deeper on Cutaneous sensory nerve excitability.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutaneous sensory nerve excitability.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call